{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:21:30Z","timestamp":1782516090192,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cjca.2023.10.017","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:12:08Z","timestamp":1698556328000},"page":"422-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of Predictive Information From Biomarkers Added to Clinical Models of Preeclampsia: Consideration of PAPP-A2, Activin A, and sFlt-1:PlGF Ratio"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-2549","authenticated-orcid":false,"given":"Stella S.","family":"Daskalopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Labos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Kuate Defo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.10.017_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.10.017_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.cjca.2023.10.017_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.10.017_bib4","first-page":"1591","article-title":"Development and internal validation of a risk prediction model for acute cardiovascular morbidity in preeclampsia","volume":"38","author":"Malham\u00e9","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.10.017_bib5","first-page":"1934","article-title":"Association of preeclampsia with myocardial injury among patients undergoing noncardiac surgery: the PREECLAMPSIA-VISION study","volume":"37","author":"Zen","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.10.017_bib6","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US Preventive Services Task Force recommendation statement","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.10.017_bib7","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib8","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.10.017_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjca.2023.10.017_bib11","article-title":"PAPP-A2 and inhibin A as novel predictors for pregnancy complications in women with suspected or confirmed preeclampsia","volume":"9","author":"Neuman","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2023.10.017_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000490385","article-title":"External validation and clinical usefulness of first trimester prediction models for the risk of preeclampsia: a prospective cohort study","volume":"45","author":"Meertens","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.cjca.2023.10.017_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10641955.2019.1584210","article-title":"External validation of prognostic models for preeclampsia in a Dutch multicenter prospective cohort","volume":"38","author":"Lamain-de Ruiter","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.cjca.2023.10.017_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/uog.13435","article-title":"First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort","volume":"44","author":"Oliveira","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2023.10.017_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cjca.2023.10.017_bib16","doi-asserted-by":"crossref","first-page":"199.e1-13","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","article-title":"Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy End Points (SCOPE) international cohort study","volume":"64","author":"Kenny","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.10.017_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12958-022-01003-3","article-title":"Diagnostic biomolecules and combination therapy for pre-eclampsia","volume":"20","author":"Qi","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.cjca.2023.10.017_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MNH.0000000000000870","article-title":"Novel therapeutic and diagnostic approaches for preeclampsia","volume":"32","author":"Vatish","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cjca.2023.10.017_bib20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/IJWH.S283239","article-title":"Reviewing accuracy of first trimester screening for preeclampsia using maternal factors and biomarkers","volume":"14","author":"Malone","year":"2022","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.cjca.2023.10.017_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.placenta.2015.11.004","article-title":"Differential expression of human placental PAPP-A2 over gestation and in preeclampsia","volume":"37","author":"Kramer","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.cjca.2023.10.017_bib22","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1159\/000489685","article-title":"CircRNA-0004904, CircRNA-0001855, and PAPP-A: potential novel biomarkers for the prediction of preeclampsia","volume":"46","author":"Jiang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.cjca.2023.10.017_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-7498-6_4","article-title":"Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia","volume":"1710","author":"Hobson","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cjca.2023.10.017_bib24","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001604R","article-title":"Activin A increases human trophoblast invasion by upregulating integrin \u03b21 through ALK4","volume":"35","author":"Zhu","year":"2021","journal-title":"Faseb j"},{"key":"10.1016\/j.cjca.2023.10.017_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preghy.2019.12.012","article-title":"The role of follistatin and granulocyte-colony stimulating factor in HIV-associated pre-eclampsia","volume":"19","author":"Mdlalose","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.cjca.2023.10.017_bib26","doi-asserted-by":"crossref","first-page":"82.e1","DOI":"10.1016\/j.ajog.2014.07.052","article-title":"Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia","volume":"212","author":"Rasanen","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib27","doi-asserted-by":"crossref","first-page":"833.e1-e20","DOI":"10.1016\/j.ajog.2021.11.1366","article-title":"Sleep-disordered breathing in high-risk pregnancies is associated with elevated arterial stiffness and increased risk for preeclampsia","volume":"226","author":"Phan","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154794","article-title":"A\u00a0longitudinal analysis of arterial stiffness and wave reflection in preeclampsia: identification of changepoints","volume":"120","author":"Phan","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cjca.2023.10.017_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2023.10.017_bib30","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2023.10.017_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.cjca.2023.10.017_bib32","first-page":"549","article-title":"The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.10.017_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/1471-0528.17430","article-title":"Arterial stiffness for the early prediction of pre-eclampsia compared with blood pressure, uterine artery Doppler and angiogenic biomarkers: a prospective cohort study","volume":"130","author":"Phan","year":"2023","journal-title":"Bjog"},{"key":"10.1016\/j.cjca.2023.10.017_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.cjca.2023.10.017_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/SPV.0000000000000979","article-title":"We should abandon \u201crace\u201d as a biological category in biomedical research","volume":"26","author":"Umek","year":"2020","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.cjca.2023.10.017_bib36","doi-asserted-by":"crossref","first-page":"S876","DOI":"10.1016\/j.ajog.2020.07.038","article-title":"Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature","volume":"226","author":"Johnson","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2023.10.017_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwu140","article-title":"Correcting for optimistic prediction in small data sets","volume":"180","author":"Smith","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2023.10.017_bib39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.10.017_bib40","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.10.017_bib41","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.10.017_bib42","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.10.017_bib43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41440-019-0224-8","article-title":"The potential role of pregnancy-associated plasma protein-A2 in angiogenesis and development of preeclampsia","volume":"42","author":"Chen","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2023.10.017_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.preghy.2021.05.024","article-title":"Serum inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women","volume":"25","author":"Keikkala","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.cjca.2023.10.017_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39564","article-title":"Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US women","volume":"4","author":"Boakye","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2023.10.017_bib46","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1080\/14767058.2019.1581522","article-title":"Preeclampsia outcomes at delivery and race","volume":"33","author":"Gyamfi-Bannerman","year":"2020","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cjca.2023.10.017_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"Magee","year":"2022","journal-title":"Preeclampsia. N Engl J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23018457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23018457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:53:12Z","timestamp":1760107992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23018457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0828282X23018457"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.10.017","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Predictive Information From Biomarkers Added to Clinical Models of Preeclampsia: Consideration of PAPP-A2, Activin A, and sFlt-1:PlGF Ratio","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}